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Background & aims: It is unclear whether advising a prudent breakfast alone is sufﬁcient to improve
blood lipids and cardiometabolic risk factors in overweight hypercholesterolemic subjects. The aim of
this study was to investigate whether a prudent low-fat breakfast (PB) rich in dietary ﬁber lowers low-
density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors in subjects with elevated
LDL-cholesterol levels.
Methods: In a parallel, controlled, 12-week study, 79 healthy overweight subjects (all regular breakfast
eaters) were randomly allocated to a group that received a PB based on Nordic foods provided ad libitum
or a control group that consumed their usual breakfast. The primary outcome was plasma LDL-C. Sec-
ondary outcomes were other blood lipids, body weight, sagittal abdominal diameter (SAD), glucose
tolerance, insulin sensitivity and inﬂammation markers (C-reactive protein [CRP] and tumor necrosis
factor receptor-2 [TNF-R2]), and blood pressure. The PB was in accordance with national and Nordic
nutrition recommendations and included oat bran porridge with low-fat milk or yogurt, bilberry or
lingonberry jam, whole grain bread, low-fat spread, poultry or fatty ﬁsh, and fruit.
Results: No differences were found in LDL-C, other blood lipids, body weight, or glucose metabolism, but
SAD, plasma CRP, and TNF-R2 decreased more during PB compared with controls (p < 0.05). In the
overall diet, PB increased dietary ﬁber and b-glucan compared with controls (p < 0.05).
Conclusions: Advising a prudent breakfast for 3 months did not inﬂuence blood lipids, body weight, or
glucose metabolism but reduced markers of visceral fat and inﬂammation.
The trial was registered in the Current Controlled Trials database (http://www.controlled-trials.com);
International Standard Randomized Controlled Trial Number (ISRCTN): 84550872
 2014 The Authors. Published by Elsevier Ltd and European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).1. Introduction
Eating breakfast has been associated with a reduced risk of
obesity and cardiometabolic disease, potentially through mecha-
nisms involved in energy balance andmetabolism [1]. The morning
meal may inﬂuence hormones and metabolic factors involved
appetite regulation, energy utilization and storage, and blood
glucose control [2].
Eating breakfast generally appears to be associated with favor-
able effects on cardiometabolic risk factors [3e5]. Surprisingly little
data, however, are available on the role of the dietary composition
of the breakfast. To our knowledge, no controlled study hasrus).
Ltd and European Society for Clini
d/3.0/).investigated whether a breakfast with a food composition that is in
line with general dietary recommendations has beneﬁcial effects
on cardiometabolic risk factors compared with a control breakfast
in healthy individuals.
The American Heart Association recommends eating three
meals per daydbreakfast, lunch, and dinnerdto help control binge,
emotional, and nighttime eating [6]. A morning meal, preferably
with high-ﬁber, carbohydrate-rich foods that contribute 20e25
energy percent (E%) within 1e2 h after an overnight fast is advised
by the 2004 Nordic Nutrition recommendations [7].
Distinguishing between promoting breakfast consumption and
promoting a prudent breakfast is important. Eating breakfast on a
regular basis has been related to increased dietary quality of the
entire day’s diet [8e10]. Eating a prudent breakfast (PB) can
improve the quality of the entire day’s nutrient intake [9,11].cal Nutrition and Metabolism. This is an open access article under the CC BY-NC-ND
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term metabolic effects of breakfast quality [12], but no studies
have investigated the quality of a whole breakfast and its inﬂuence
on cardiometabolic risk proﬁles in healthy adults. Therefore,
intervention studies are needed to determine whether the quality
of breakfast can improve cardiometabolic risk proﬁles in subjects
who already eat breakfast. A diet that is in accordance with Nordic
nutrition recommendations for all meals during the day has been
shown tomarkedly lower low-density lipoprotein cholesterol (LDL-
C) and improve several cardiovascular risk factors in hyper-
lipidemic subjects in 6 weeks [13]. The aim of the present ran-
domized trial was to investigate whether the intake of a PB alone
can reduce LDL-C levels and other cardiometabolic risk markers
and improve fasting or postprandial glucose metabolism in healthy
hypercholesterolemic individuals.
2. Material and methods
2.1. Subjects
Subjects were recruited by advertisements in local newspapers
in Uppsala, Sweden, and the study was conducted between august
2009 and January 2010. After screening 79 overweight and mildly
hypercholesterolemic but otherwise healthy men and womenwere
included in the study (Fig. 1). The inclusion criteria were eating
breakfast on a regular basis, 25e67 years of age, plasma LDL-C
3.0 mmol/L, body mass index (BMI) 25 and 31 kg/m, and he-
moglobin concentration120 g/L for women and130 g/L formen.
The exclusion criteria were use of lipid-lowering drugs, high blood
pressure (BP) (deﬁned as BP > 155/95 mmHg), regular use of di-
etary supplements fortiﬁed with plant sterols or polyunsaturated
fatty acids (e.g., omega-3), slimming or medically prescribed diet/
medication, special diet (e.g., vegan or gluten-free), and aversion to
eating porridge or having herring or mackerel for breakfast for 12
weeks. Written informed consent was provided by all subjects, and
the study was approved by the regional ethical committee in
Uppsala.Fig. 1. Flow diagram of the phas2.2. Outcome measures
The primary outcome measure was plasma LDL-C concentra-
tions. Secondary outcomes were body weight, plasma total
cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), LDL-
C/HDL-C ratio, triglycerides (TGs), Apo lipoprotein A1 and B (ApoA1
and ApoB), ApoB/ApoA1 ratio, glucose tolerance, hemoglobin A1c
(HbA1c), insulin sensitivity, sagittal abdominal diameter (SAD),
tumor necrosis factor receptor-2 (TNF-R2), C-reactive protein (CRP),
and blood pressure.
2.3. Study design
The study was a parallel, randomized, controlled, intervention
study in free-living subjects (Fig. 1). Subjects were randomly
assigned to one of two groups for 12 weeks: control breakfast or PB.
The sole intervention of this study was the instruction to eat a
breakfast composed of healthy Nordic foods, in accordance with
Nordic dietary recommendations [13]. Participants in the PB were
provided with all breakfast items. Beverages were, however, not
provided to the PB. The intervention group was encouraged to
otherwise maintain their usual lifestyle. The control group was
encouraged to maintain their usual breakfast habits and maintain
their usual dietary or lifestyle habits during the study. The subjects
in the control group were offered the PB for 3 weeks after
completing the study. This offer was made in an attempt to
decrease the number of drop-outs in the control group.
Subjects that met the eligibility criteria and signed the informed
consent were assigned a randomization number. Randomization
was performed by personnel at Good Food Practice (GFP). A study
nurse enrolled and assigned participants into the study in accor-
dance with the randomization procedure. A randomization treat-
ment code list was generated by an independent contract research
organization (Good Food Practice), unavailable to all study in-
vestigators. The ﬁrst eligible subject received the ﬁrst number in
the randomization number list, and the second subject received the
second number, and so on. The investigational products were sentes of the randomized trial.
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this trial and supporting CONSORT checklist are available as
Supporting information.
3. Intervention
3.1. Prudent breakfast
As shown in Table 1, the PB included porridge (oat bran) with
low-fat milk or yogurt, a choice of bilberry or lingonberry jam,
raisin, fruit, whole-grain bread, low-fat spread that is high in
polyunsaturated fatty acids, turkey meat, and pickled herring or
mackerel in tomato for use on the whole-grain bread (Table 1).
4. Dietary assessment
Although the intervention concerned breakfast only we also
collected dietary intake data during the whole day, thus wewanted
to investigate if the breakfast intervention inﬂuenced total dietary
intake in both groups. Participants in the control group and PB
completed a 3-day food record at baseline and after 12 weeks to
obtain data on the overall dietary intake during the study period
[14]. The food record was a pre-coded menu book that was evalu-
ated by the National Food Administration in Sweden and was
supplemented with whole-grain and high-ﬁber products for the
present study. To monitor dietary compliance in the PB group, the
subjects received a study diary that included a list and amounts of
foods to be included in the PB. The subjects were asked to ﬁll in the
date and mark the foods they consumed and any possible failure to
consume the food items in the PB. Dietist XP version 3.0, a com-
puter program based on the Swedish National Food Administration
database (2005-02-01), was used to calculate the nutrient content
of the PB and the 3-day food record. The Glycemic Index (GI) for the
control breakfast from the 3-day food record at 12 weeks, and GI for
the planned PB (Table 1), was calculated according to FAO/WHO
[15]. Foods containing less than 15 g carbohydrates per 100 g was
excluded.Table 1
Quantity and frequency of food items included in the prudent breakfast.
Quantity Frequency
Porridge
Oat bran. As an alternative
to porridge, oat bran-
enriched muesli could
be eaten
40 g per serving
(corresponding to 3 g
b-glucan per day)
Oat bran porridge: 5e7
days per week
Oat bran enriched
muesli: Not more than
2 days per week
Low-fat milk or yogurt Maximal amount, 4 dl Each breakfast
Jam, raisins 1e2 tbsp (17 g) of
each
Each breakfast
Fresh or frozen fruit or
berries
Corresponding to 1
fruit
Each breakfast
Psyllium 1.5 tsp (7 g) 7 days per week
Linseed 1.5 tsp (7 g) 7 days per week
Table salt Do not exceed recipe
on package
Use low-sodium table
salt
Sandwich
Soft or hard whole-grain
bread, 50% whole grain
as dry matter
One soft slice (40 g) or
two hard slices (24 g)
Each breakfast. Subjects
had to eat bread until
satiated. Subjects were
allowed to have more
or less bread to regulate
satiety.
Low-fat spread (38% fat) 5 g per slice of bread
Turkey meat One slice (20 g) 4 days per week
Pickled herring or
mackerel
Two to three pieces
(10e15 g) of herring
or 1 tbsp mackerel
3 days per week5. Biochemical assessment
The analyses included in the lipid proﬁle were fasting LDL-C, TC,
HDL-C, and TG. An oral glucose tolerance test (OGTT) was per-
formed, i.e. 75 g glucose dissolved in 350 ml water. Plasma glucose
and serum insulin were measured at 0, 30, 60, 90, and 120 min.
6. Clinical assessment
The subjects visited the clinic in the morning after a 12-h fast.
Body weight was measured (kg) on a digital scale with subjects
wearing light clothing and no shoes. Height was measured to the
nearest 0.5 cm. BMI was calculated as weight (kg) divided by height
(m) squared.
SAD, a valid marker of visceral fat [18,19], was measured after a
normal expiration to the nearest 0.1 cm in the supine position with
bent legs on a ﬁrm examination table, without clothes in the
measurement area [14]. At the level of the iliac crest, the SAD was
measured using a ruler and water level. The SAD was the distance
between the examination table and the horizontal level [16]. BP
was measured oscillometrically (Omron M4-1, Omron Healthcare
Europe B.V, Hofddorp, The Netherlands) in a sitting position on the
right arm after a resting period of 3e5min. BPwas calculated as the
average of three measurements.
7. Biochemical analysis
Blood samples were drawn from an antecubital vein using
vacutainer tubes. The samples were handled according to sample
treatment instructions provided by the Centre for Laboratory
Medicine, Clinical Chemistry, Uppsala University Hospital, which
performed the analyses according to their routine practice. Plasma
LDL-C, TC, HDL-C, TG, and glucose were measured by enzymatic
reactions, and plasma high sensitivity CRP, ApoA1 and ApoB were
measured using immunoturbidometric assays and an Architect C
8000 instrument from Abbott (Abbott Park, IL, USA). Serum insulin
was measured using a sandwich immunosorbent assay on a Cobas
E601 immunology analyzer from Roche (Mannheim, Germany).
Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) was
calculated as plasma insulin  glucose/22.5 [17].
Soluble TNF-R2 (or Type A, type a, or 75 kDa) was measured in
plasma by commercial sandwich ELISA (DY726, R&D Systems,
Minneapolis, MN, USA). The concentrations in the samples were
determined by comparing the optical density of the sample with
the standard curve. The assay had a total coefﬁcient of variation
(CV) of approximately 7% andwas calibrated against highly puriﬁed
recombinant human peptides.
8. Statistical analyses
The data are expressed as mean  standard deviation (SD) or
standard error of mean (SEM), and median (interquartile range).
For dietary intake data, the distribution was examined by the
ShapiroeWilks test. Non-normally distributed variables were
logarithmically transformed; if they did not achieve normality, then
nonparametric tests were used. Statistical analyses for dietary
intake were based on intention-to-treat principles.
Differences between groups in dietary intake were analyzed
using an unpaired two-tailed t-test for normally distributed data
and an independent-sample ManneWhitney U-test for non-
normally distributed data. Linear mixed-effects models were used
to assess effects of treatment on cardiometabolic risk factors during
the intervention. Restricted maximum likelihood method was used
to ﬁt models andmissing observations were ignored. The risk factor
of interest was included in the model as dependent variable while
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point (baseline or end of the intervention) and the study group *
time point interaction was included as covariates. Analyses were
also performed using extendedmodels including age, sex, and body
weight as additional covariates. The p-values presented represent
those of the models’ study group * time point interaction term and
display the statistical signiﬁcance of study group effects on risk
factors during the intervention. Observations with CRP 10 mg/L
were excluded before analyses of CRP and TNF-R2.
The AUCs for insulin and glucose concentrations during the
OGTT were calculated according to the trapezoid rule. Correlations
were tested using Pearson’s correlation and linear regression
analyses.
For nutrient data, paired t-tests were used to explore within-
group changes between baseline and at 12 weeks. Nutrients, not
normally distributed after logarithmically transformation data, are
presented as median 25th and 75th percentiles (interquartile
range).
We calculated statistical power based on dose-response studies
using b-glucan as well as our previous trial where the present
breakfast was included in a whole diet [13,18,19]. Based on our
previous study using a comparable PB to the current one, it was
estimated that detecting a difference between groups in LDL-C of
0.4 mmol/L, with an estimated SD of 0.60, n ¼ 36 subjects were
needed in each group with a power of 80% (a ¼ 0.05). A p-value
<0.05 was considered statistically signiﬁcant for the primary
outcomemeasure. P-values for secondary endpoints are considered
as supportive to the primary analysis. Statistical analyses were
performed using IBM SPSS 19 software.Table 39. Results
Of the 79 subjects randomly assigned to the two groups (31men
and 48 women), one subject dropped out from the study (Fig. 1).
With the exception of ApoA1 and serum insulin (AUC), no signiﬁ-
cant differences were found between the PB and control breakfast
groups at baseline with regard to clinical characteristics (Table 2).Table 2
Baseline characteristics after randomization.a
Characteristics Control
breakfast
(n ¼ 40)
Prudent
breakfast
(n ¼ 38)
p
Age (years) 54.4  9 54.9  7.8
Sex, men/women, n (%) 17/23 (42/58) 14/25 (36/64)
Body weight (kg) 84.7  13.1 82.5  10.2 0.408
Body mass index (kg/m2) 28.5  2.4 28.2  2.5 0.585
Plasma LDL-C (mmol/L) 4.1  0.7 4.2  0.8 0.778
Plasma total cholesterol (mmol/L) 6.3  0.9 6.5  1.1 0.330
Plasma HDL-C (mmol/L) 1.4  0.3 1.5  0.4 0.148
LDL-C/HDL-C ratio 3.2  0.8 3.0  0.8 0.284
Plasma triglycerides (mmol/L) 1.53  1.04 1.6  0.7 0.703
Plasma ApoA1 (g/L) 1.4  0.2 1.5  0.2 0.034
Plasma ApoB (g/L) 1.1  0.2 1.2  0.2 0.693
ApoB/ApoA1 ratio 0.83  0.23 0.78  0.21 0.277
Plasma glucose (mmol/L) 0 min 5.3  0.6 5.4  0.8 0.988
Plasma glucose (AUC) 915  236 818  133 0.09
Serum insulin (mU/L) 0 min 8.4  4.4 8.8  5.4 0.872
Serum insulin (AUC) 7497  4769 4742  2308 0.012
HOMA-IR 2.0  1.2 2.2  1.7 0.822
Sagittal abdominal diameter (cm) 22.3  2.0 22.4  2.1 0.922
C-reactive protein (mg/L)b 1.9  1.4 2.2  1.8 0.424
Systolic blood pressure (mmHG) 124  13.1 125.8  11.5 0.404
Diastolic blood pressure (mmHG) 76.8  7.7 79.0  7.7 0.208
a The data are expressed as the mean  SD.
b Subjects with baseline CRP 10 mg/L were excluded.No difference in HbA1c was found between groups (p ¼ 0.92; data
not shown). No adverse events were reported in either group.
9.1. Effects of the prudent breakfast on dietary intake
When comparing breakfast intake at 12 weeks (Table 3) with
breakfast intake at baseline in PB, signiﬁcant increases were
observed in the intake of protein as a percentage of energy (E%),
dietary ﬁber, b-glucan, and polyunsaturated fat (p < 0.05). Signiﬁ-
cant decreases were observed in total fat (E%), saturated fat,
monounsaturated fat, dietary cholesterol, and sodium (p < 0.05).
No differences in energy intake, carbohydrates (E%), and whole
grain intake were observed (Table 3). Signiﬁcant changes in whole-
day nutrient intake were found with regard to alcohol (E%), car-
bohydrate (E%), dietary ﬁber, and b-glucan from baseline to 12
weeks in the PB group compared with the control group (Table 4).
GI for the control breakfast from the 3-day food record at 12 weeks
was 75  0.23 and for the planned PB, GI was 56 (Table 3).
9.2. Effects on cardiometabolic risk factors
No signiﬁcant group differences in effects on plasma LDL-C, TC,
HDL-C, the HDL/LDL ratio, TG, or the ApoB/ApoA1 ratio were found
(Table 5). No differences were observed between groups in body
weight, plasma glucose, serum insulin, glucose and insulin AUC,
HOMA-IR, or systolic and diastolic BP (all p > 0.14). HbA1c was not
inﬂuenced by the diets (data not shown).
SAD (Table 5) and plasma levels of CRP and TNF-R2 (Fig. 2(a) and
(b)) were signiﬁcantly decreased by the PB compared with the
control breakfast (p < 0.05). The absolute changes in CRP and TNF-
R2 between baseline and 12 weeks were 0.66  0.30 (þ37%) for the
control breakfast and0.710.27 (30%) for the PB and 359 118
(þ9%) for the control breakfast and 66  88 (þ2%) for the PB,
respectively. The change in CRP was weakly associated with the
change in TNF-R2 (r ¼ 0.38, p < 0.05, n ¼ 64).Daily energy and nutrient intake of actually consumed prudent breakfast in the
control breakfast groupa and prudent breakfast group during 12 weeks.b
Control
breakfast
(n ¼ 40)
Prudent
breakfast
(n ¼ 38)
Energy (kcal) 386  142 356  49
Protein (E%) 19  6 231c
Carbohydrates (E%) 50  11 52  2
Dietary ﬁber (g) 5  2.6 12  1.5c
b-glucan (g) 0.2  0.3 2.0  0.3c
Whole grain (g) 22  15 14  4
Fat (E%) 30  9 251d
Saturated fat (E%) 13  5 6  0d
Monounsaturated fat (E%) 9  4 6  1d
Polyunsaturated fat (E%) 4  2 8  1c
Dietary cholesterol (mg) 82  105 20  13d
Sodium (mg) 557  366 317  66d
Glycemic Indexe 75  0.23 56
a The data are expressed as mean  SD, and is based on a 3-day food record.
Paired t-test was used to assess changes within groups between baseline and at 12
weeks.
b The data are expressed as mean  SD, and is based on the study diary. Paired t-
test was used to assess changes within groups between baseline and at 12 weeks.
c Signiﬁcant increases were observed in the intake of protein as a percentage of
energy (E%), dietary ﬁber, b-glucan, and polyunsaturated fat (p < 0.05) when
comparing breakfast intake at 12 weeks with breakfast intake at baseline within PB.
d Signiﬁcant decreases were observed in total fat (E%), saturated fat, mono-
unsaturated fat, dietary cholesterol, and sodium (p < 0.05). No differences in energy
intake, carbohydrates (E%), and whole grain intake were observed.
e GI for the control breakfast was calculated as a mean of 12 weeks and GI for the
PB, was for the planned PB.
Table 4
Nutrient intake at baseline and 12 weeks in the control group and prudent breakfast group.a,b
Nutrients Control breakfast Prudent breakfast
Baseline
n ¼ 40
12 weeks
n ¼ 40
pc Baseline
n ¼ 38
12 weeks
n ¼ 38
pc pd
Energy (kcal/day) 1819  517 1917  498 0.18 1886  488 1921  366 0.724 0.581
Protein (E%) 17  3 17  2 0.320 16  2 18  2 0.012 0.378
Alcohole (E%) 0.00(0.00e0.04) 0.04(0.00e0.08) <0.05 0.03(0.00e0.07) 0.02(0.00e0.04) 0.21 <0.05
Carbohydrates (E%) 45  6 42  6 <0.05 43  6 44  5 0.401 <0.05
Dietary ﬁber (g/day) 20  6 21  7 0.093 20  5 26  7 0.000 <0.05
b-glucane (g/day) 0.00(0.00e0.40) 0.40(0.00e1.80) <0.05 0.00(0.00e0.40) 1.80(0.30e2.60) 0.000 <0.05
Whole grain (g/day) 37  22 35  24 0.527 35  24 40  18 0.335 0.250
Fat (E%) 36  6 35  6 0.682 35  5 34  5 0.647 0.980
Saturated fate (E%) 13(11e15) 13(12e15) 0.789 13(12e15) 13(10e15) 0.053 0.093
Monounsaturated fat (E%) 14  4 12  2 0.29 12  2 12  2 0.989 0.387
Polyunsaturated fat (E%) 6  2 6  2 0.325 5.6  2 5.9  2 0.196 0.764
Dietary cholesterole (mg/day) 264(193e350) 270(232e358) 0.388 309(241e386) 284(230e319) 0.096 0.080
Sodium (mg/day) 2854  1107 2839  939 0.576 2863  755 2939  728 0.510 0.936
a The data are expressed as mean  SD for normally distributed variables and median (interquartile range) for non-normally distributed variables after logarithmic
transformation.
b Data is based on 3-day food records.
c Differences within group were analyzed using paired samples t-test.
d Differences in change between groups were analyzed using an unpaired two-tailed t-test for normally distributed data and an independent-sample ManneWhitney U-test
for non-normally distributed data.
e Variables that were not normally distributed after logarithmic transformation.
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The present randomized controlled trial investigated whether a
PB alone improves cardiometabolic risk factors compared with a
control group that consumed their usual breakfast. In contrast to
our hypothesis, however, a PB in line with a healthy Nordic diet rich
in dietary ﬁber and unsaturated fats and low in total fat had no
effect on blood lipids, glucose metabolism, or body weight. How-
ever, signiﬁcant reductions of SAD, a marker of visceral fat, and
circulating plasma inﬂammation markers were found in the PB
group compared with controls. CRP concentrations were reduced
by 23% after PB despite groups were weight stable.
Previous studies of the effects of eating breakfast on health
mainly explored the effect of eating breakfast per se compared with
skipping breakfast, suggesting that omitting breakfast both in the
short-term [3] and long-term [5] increases LDL-C and fastingTable 5
Changes in cardiometabolic risk factors from baseline to 12 weeks during control breakf
Characteristics Control breakfast
(n ¼ 40)
Body weight (kg) 0.62  0.29
Plasma LDL-C (mmol/L) 0.005  0.06
Plasma total cholesterol (mmol/L) 0.002  0.07
Plasma HDL-C (mmol/L) 0.05  0.02
LDL-C/HDL-C ratio 0.09  0.06
Plasma triglycerides (mmol/L) 0.04  0.05
Plasma ApoA1 (g/L) 0.04  0.02
Plasma ApoB (g/L) 0.004  0.01
ApoB/ApoA1 ratio 0.02  0.01
Plasma glucose (mmol/L) 0 min 0.00(0.18 to 0.30)
Plasma glucose (AUC)c 27.8(117.8 to 62.6)
Serum insulin (mU/L) 0 min 0.40(0.40 to 1.80)
Serum insulin (AUC)d 285(1484 to 1646)
HOMA-IR 0.27  0.20
Sagittal abdominal diameter (cm) 0.24  0.19
Systolic blood pressure (mmHG) 2.6  1.18
Diastolic blood pressure (mmHG) 2.2  0.80
The data are mean  SEM, and median (interquartile range). Differences between group
a Crude model without adjusmtents.
b Crude model adjusted for age, sex and body weight.
c Plasma glucose AUC: control breakfast, n ¼ 34; prudent breakfast, n ¼ 35.
d Serum insulin AUC: control breakfast, n ¼ 30; prudent breakfast, n ¼ 34.insulin concentrations. However, in a six month parallel designed
randomized study, investigating the effects of high- versus low GI
cereal breakfast, or a MUFA rich breakfast in subjects with type 2
diabetes, no signiﬁcant differences between groups in fasting LDL-
cholesterol, triglycerides, glycaemia or body weight were observed
[12]. Thus, those ﬁndings in patients with diabetes accord well with
the current study in healthy subjects. The ratio of total to HDL-
cholesterol was however higher in patients who consumed the
high-GI cereal than in the MUFA group at 3 months but not at 6
months in that study [12]. In the present study, all of the subjects
were regular breakfast eaters because our aim was to investigate
the role of breakfast nutrient quality. Breakfast is recommended to
contribute to 20e25% of energy intake [7], and breakfast is only one
part of the entire day’s diet. Comparisons of the nutrient compo-
sition of the PB between baseline and at 12 weeks indicated sig-
niﬁcant changes in several nutrients, including protein, dietaryast and prudent breakfast.
Prudent breakfast
(n ¼ 38)
pa pb
0.28  0.23 0.316 n/a
0.07  0.09 0.528 0.494
0.11  0.10 0.369 0.436
0.003  0.02 0.078 0.099
0.07  0.08 0.725 0.798
0.06  0.10 0.641 0.588
0.04  0.02 0.663 0.964
0.023  0.02 0.363 0.392
0.034  0.02 0.661 0.775
0.10(0.10 to 0.20) 0.808 0.795
12.0(130.5 to 30.0) 0.511 0.502
0.20(2.10 to 1.60) 0.123 0.135
374(1755 to 519) 0.579 0.432
0.12  0.13 0.128 0.141
0.38  0.18 0.038 0.034
1.9  1.20 0.535 0.576
0.62  0.85 0.386 0.396
s are assessed by Linear mixed effects models.
Fig. 2. (a) Change in C-reactive protein (CRP) during the intervention in participants in
the control breakfast and prudent breakfast groups, mean  SEM. CRP was signiﬁcantly
decreased by the PB compared with the control breakfast (p < 0.05). (b) Change in
tumor necrosis factor receptor 2 (TNF-R2; pg/ml) during the intervention in partici-
pants in the control breakfast and prudent breakfast groups, mean  SEM. TNF-R2 was
signiﬁcantly decreased by the PB compared with the control breakfast (p < 0.05).
V. Adamsson et al. / Clinical Nutrition 34 (2015) 20e26 25ﬁber, b-glucan, total fat, saturated fat, monounsaturated fat, poly-
unsaturated fat, dietary cholesterol, and sodium. The PB group also
exhibited signiﬁcant changes in the entire day’s nutrient intake of
alcohol (E%) carbohydrates (E%), dietary ﬁber, and b-glucan from
baseline to 12 weeks compared with the control group. Despite the
signiﬁcant change from baseline in b-glucan intake in the entire
day’s nutrient intake during PB, b-glucan intake (1.8 g) did not
reach the planned intake of 3 g per day in the PB. Because of the
dose-dependent effect of b-glucan on LDL-C and TC, we expected
that the intake of 2 g b-glucan in the PB intervention would alone
decrease LDL-C and TC by 0.11 and 0.09 mmol/L, respectively
[19]. Furthermore, the low content of saturated fat and high content
of unsaturated fats and ﬁber in the PB was expected to lower LDL-C
in addition to b-glucan. Negliable changes were however observed
in the present study,0.07 mmol/L for LDL-C and0.11 mmol/L for
TC.
Thus, despite changes in the breakfast and some signiﬁcant
changes in overall dietary intake, a lack of effect was found on LDL-
C, the primary outcome of the study. These dietary changes of the
breakfast may have been too small to inﬂuence LDL-C. We previ-
ously showed that a similar dietary intervention that included allmeals of the day had profound effects on body weight, blood lipids,
and several other cardiometabolic risk factors [13].
Food intake in themorningmay be particularly satiating and can
reduce the total amount of energy ingested during the day, thereby
preventing obesity [8]. In the present study, no signiﬁcant changes
in entire-day energy intake, body weight, BMI, or waist measure-
ment were observed. However, a signiﬁcant reduction of the SAD
was found, possibly indicating reduced visceral fat content that is
not captured by changes in waist girth [20,21]. The latter is sub-
jected to higher measurement error than the SAD and thus less
sensitive to small changes in abdominal fat content [22]. Never-
theless, this ﬁnding should be interpreted with caution because no
trend toward a lower waist girth was found in the PB group. The
reduced levels of CRP and TNF-R2, despite lack of weight change,
are an interesting ﬁnding that may accord with the reduced SAD. A
close link has been reported between visceral fat and low-grade
systemic inﬂammation [23]. The dietary components responsible
for this effect are unclear, but may involve improved fat quality of
the diet. E.g. polyunsaturated fatty acids (both n-3 and n-6) in place
of saturated fats can reduce the visceral fat-to-subcutaneous fat
ratio and reduce inﬂammation markers, such as TNF-R2, as shown
in a recent dietary fat modiﬁcation study [24]. Dietary ﬁber, another
key component of the PB, may also inﬂuence inﬂammationmarkers
as shown in recent controlled interventions in which reduced CRP
concentrations were observed after high-ﬁber diets [25,26]. The
mechanisms for such associations are unclear but may involve
ﬁber-induced increase of short-chain fatty acids (e.g.butyrate) in
colon, which may counteract inﬂammatory processes, whereas a
high-fat diet might instead reduce the production of butyrate [27].
The main source of dietary ﬁber in PB was oats and as the source of
dietary ﬁber may be of importance in reduction of inﬂammatory
markers the breakfast composition might have contributed to the
change in inﬂammatory markers in PB [26]. The signiﬁcantly lower
level of two independent inﬂammation markers in the current
study suggests that this ﬁnding was unlikely caused by chance.
Indeed, a direct association was found between CRP and TNF-R2.
One could speculate that apart from a role of dietary ﬁber as indi-
cated above, a reduction in saturated fat and increase in poly-
unsaturated fat might lower certain systemic inﬂammation
markers [24], possibly by inﬂuencing inﬂammatory gene expres-
sion An increased intake of ﬁsh might also inhibit inﬂammatory
process, although the evidence is inconsistent [28].
No effects on fasting insulin sensitivity, glucose tolerance, or
insulin response in the OGTT were found. Improving glucose
metabolism in non-diabetic subjects by altering breakfast habits
alone is likely difﬁcult to achieve without caloric restriction and
weight loss. The present study has some limitations. As our study
was powered to detect a difference between groups of 0.4 mmol/l
in LDL-C, the present sample size may not be sufﬁcient to detect
smaller differences. However, if that would have been the case,
such small effect on LDL-C would most likely be of little clinical
importance. We did not monitor physical activity in the groups.
However, both groups were encouraged to maintain their usual
lifestyle, including their level of physical activity, during the
study. We did not perform an intermediary dietary evaluation
during the study (besides at baseline and 12-weeks) which may
be a possible limitation since subjects could have changed their
intake in that intermediate period during the three months of the
study.
The strengths of the study include the randomized controlled
design, exceptionally low drop-out rate, and inclusion of both men
and women. Also, the study provided all food to the PB subjects.
The latter allowed us to monitor compliance with study breakfast
more accurately by using a study diary that recorded any deviations
from the planned breakfast.
V. Adamsson et al. / Clinical Nutrition 34 (2015) 20e2626In conclusion, advising a PB based on Nordic foods rich in di-
etary ﬁber and low in fat had no favorable effects on blood lipids,
glucose metabolism, or body weight but reduced markers of
visceral fat and inﬂammation.
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